Doctronic navigation menu Log In
Doctronic navigation menu

Contents
  • What is Suppressive Therapy?
  • Benefits Beyond Outbreaks
  • Who Should Consider It?

Suppressive Therapy: A New Normal for Genital Herpes?

Suppressive Therapy: A New Normal for Genital Herpes?

Next Steps

Suppressive therapy could be a game changer for those frequently troubled by genital herpes. Find out how it works and if it's right for you.
Contents
  • What is Suppressive Therapy?
  • Benefits Beyond Outbreaks
  • Who Should Consider It?

What is Suppressive Therapy?

Suppressive therapy involves taking antiviral medications daily to prevent outbreaks of genital herpes. This approach is ideal for individuals experiencing frequent recurrences, as it can dramatically decrease the number of outbreaks and their severity.

Benefits Beyond Outbreaks

Suppressive therapy not only reduces outbreak frequency but also decreases the risk of transmitting the virus to sexual partners. This is especially important for those in relationships with uninfected partners, offering peace of mind and reducing the chance of transmission.
Suppressive therapy involves taking antiviral medications daily to prevent outbreaks of genital herpes, significantly reducing outbreak frequency and severity.

Who Should Consider It?

Individuals with six or more outbreaks per year or those with significant anxiety about transmission benefit the most from suppressive therapy. It's also a good option for those who want a simplified routine with fewer outbreaks to manage.

FAQs

What is suppressive therapy?

Suppressive therapy is daily antiviral treatment to prevent herpes outbreaks.

Does it help with transmission?

Yes, it reduces the risk of transmitting the virus to partners.

Who should use suppressive therapy?

Those with frequent outbreaks or anxiety about transmission should consider it.

Key Takeaways

Suppressive therapy can be a practical option for those struggling with frequent genital herpes outbreaks.
Consider discussing suppressive therapy with Doctronic for a comprehensive management plan.
Additional References
  1. Reitano M, Tyring S, Lang W, et al. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. J Infect Dis 1998; 178:603.
  2. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.